- Report
- November 2025
- 178 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 471 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 278 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 480 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 371 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 173 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 379 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 487 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 193 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 178 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Drug Pipelines
- April 2025
- 450 Pages
Global
From €3569EUR$4,000USD£3,147GBP
€4461EUR$5,000USD£3,934GBP
- Report
- October 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- October 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- October 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- October 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- October 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- September 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- September 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- September 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- September 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP

The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more